When serious medical conditions are looking for therapies, when traditional R&D is not the answer, where do you go?
At Pfizer Regenerative Medicine we work at the forefront of science using the latest developments in stem cell biology to bring novel treatments straight to patients to prevent disability, repair failing organs, treat degenerative diseases and even slow down parts of the ageing process. Our research spans from early basic research to clinical proof of concept. We work within the Guidelines developed by the National Academy of Sciences in the USA and equivalent organisations around the world. Read more about our stem cell policy.
In 2008 we opened a new area of research where we aim to explore novel pathways. We’ve set up Pfizer Regenerative Medicine, as an entrepreneurial business unit in the UK and US to focus on delivering a new generation of innovative medicinal products.
For us, this is the start of a new era of medicine – and Pfizer Regenerative Medicine will not only be part of it, but shape it.